Publication | Closed Access
Preoperative Serum TMAO Level is a New Prognostic Marker for Colorectal Cancer
60
Citations
12
References
2017
Year
Pretreatment serum TMAO level is identified as a new independent prognostic biomarker in patients with colorectal cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1